Bank of New York Mellon Corp Has $63.48 Million Position in Sabra Healthcare REIT, Inc. $SBRA

Bank of New York Mellon Corp cut its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1.1% during the first quarter, HoldingsChannel.com reports. The firm owned 3,301,139 shares of the real estate investment trust’s stock after selling 38,106 shares during the period. Bank of New York Mellon Corp’s holdings in Sabra Healthcare REIT were worth $63,481,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. State of Michigan Retirement System lifted its position in Sabra Healthcare REIT by 2.9% in the 1st quarter. State of Michigan Retirement System now owns 60,649 shares of the real estate investment trust’s stock worth $1,166,000 after buying an additional 1,700 shares in the last quarter. Principal Financial Group Inc. boosted its position in Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares during the last quarter. Diversify Wealth Management LLC acquired a new stake in Sabra Healthcare REIT during the first quarter valued at $1,720,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in Sabra Healthcare REIT by 25.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 175,317 shares of the real estate investment trust’s stock valued at $3,371,000 after purchasing an additional 35,714 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in Sabra Healthcare REIT by 6.8% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after purchasing an additional 203,226 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Barclays began coverage on Sabra Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price target for the company. Raymond James Financial began coverage on Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating on the stock. Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Stock Down 0.3%

Shares of SBRA stock opened at $21.98 on Thursday. The stock’s 50 day simple moving average is $19.63 and its 200 day simple moving average is $19.80. Sabra Healthcare REIT, Inc. has a twelve month low of $17.17 and a twelve month high of $22.55. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The company has a market capitalization of $5.54 billion, a price-to-earnings ratio of 34.89, a PEG ratio of 1.64 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. The company’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Sabra Healthcare REIT News Summary

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Truist Financial raised its price target on Sabra Healthcare REIT from $22 to $24 and reiterated a buy rating, signaling confidence in further upside. Benzinga
• Positive Sentiment: Citizens JMP lifted its price target from $23 to $25 and maintained a market outperform rating, suggesting analysts see additional room for the stock to climb. Benzinga
• Positive Sentiment: Sabra increased FY 2026 EPS guidance to $1.53-$1.55, above the consensus estimate of $1.50, which supports the case for stronger-than-expected earnings. Business Wire
• Positive Sentiment: The company announced a major portfolio reshaping, including plans to re-tenant properties previously leased to Avamere, which may improve occupancy stability and operational quality over time. TipRanks
• Neutral Sentiment: Zacks noted SBRA was a strong recent mover on heavy volume, but also warned that recent FFO estimate revisions could limit near-term follow-through. Zacks

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.